Agent-based modeling of urban exposome interventions: prospects, model architectures, and methodological challenges. Issue 1 (10th October 2022)

• Record Type: Journal Article
• Authors: Sonnenschein, Tabea; Scheider, Simon; de Wit, G Ardine; Tonne, Cathryn C; Vermeulen, Roel
• Is Part Of: Exposome. Volume 2:Issue 1(2022)
• Publication Date: 2022-10-10
• Subjects: urban exposome -- agent-based modeling -- social cost–benefit analysis -- scenario modeling -- urban health interventions -- complex systems; Genotype-environment interaction -- Periodicals; Environmental health -- Periodicals; Environmentally induced diseases -- Periodicals; 576.8
• DOI: 10.1093/exposome/osac009
• Languages: English
• ISSNs: 2635-2265

Abstract

Abstract: With ever more people living in cities worldwide, it becomes increasingly important to understand and improve the impact of the urban habitat on livability, health behaviors, and health outcomes. However, implementing interventions that tackle the exposome in complex urban systems can be costly and have long-term, sometimes unforeseen, impacts. Hence, it is crucial to assess the health impact, cost-effectiveness, and social distributional impacts of possible urban exposome interventions (UEIs) before implementing them. Spatial agent-based modeling (ABM) can capture complex behavior–environment interactions, exposure dynamics, and social outcomes in a spatial context. This article discusses model architectures and methodological challenges for successfully modeling UEIs using spatial ABM. We review the potential and limitations of the method; model components required to capture active and passive exposure and intervention effects; human–environment interactions and their integration into the macro-level health impact assessment and social costs benefit analysis; and strategies for model calibration. Major challenges for a successful application of ABM to UEI assessment are (1) the design of realistic behavioral models that can capture different types of exposure and that respond to urban interventions, (2) the mismatch between the possible granularity of exposure estimates and the evidence for corresponding exposure–response functions, (3) the scalability issues that emerge when aiming to estimate long-term effects such as health and social impacts based on high-resolution models of human–environment interactions, (4) as well as the data- and computational complexity of calibrating the resulting agent-based model. Although challenges exist, strategies are proposed to improve the implementation of ABM in exposome research.